Cansino Biologics (China) Price History
| 688185 Stock | 61.23 0.13 0.21% |
Below is the normalized historical share price chart for Cansino Biologics extending back to August 13, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cansino Biologics stands at 61.23, as last reported on the 24th of December, with the highest price reaching 62.00 and the lowest price hitting 60.70 during the day.
If you're considering investing in Cansino Stock, it is important to understand the factors that can impact its price. Cansino Biologics appears to be very steady, given 3 months investment horizon. Cansino Biologics secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15% return per unit of risk over the last 3 months. By analyzing Cansino Biologics' technical indicators, you can evaluate if the expected return of 0.81% is justified by implied risk. Please makes use of Cansino Biologics' Mean Deviation of 3.25, downside deviation of 3.89, and Risk Adjusted Performance of 0.1237 to double-check if our risk estimates are consistent with your expectations.
At present, Cansino Biologics' Stock Based Compensation is projected to decrease significantly based on the last few years of reporting. The current year's Sale Purchase Of Stock is expected to grow to about 17.9 M, whereas Total Stockholder Equity is forecasted to decline to about 4.5 B. . Cansino Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 50.3719 | 50 Day MA 62.0746 | Beta 0.49 |
Cansino |
Sharpe Ratio = 0.1484
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 688185 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.43 actual daily | 48 52% of assets are more volatile |
Expected Return
| 0.81 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Cansino Biologics is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cansino Biologics by adding it to a well-diversified portfolio.
Price Book 3.1066 | Enterprise Value Ebitda (3.94) | Price Sales 14.2891 | Shares Float 126.9 M | Wall Street Target Price 61.34 |
Cansino Biologics Stock Price History Chart
There are several ways to analyze Cansino Stock price data. The simplest method is using a basic Cansino candlestick price chart, which shows Cansino Biologics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | November 11, 2024 | 73.75 |
| Lowest Price | September 24, 2024 | 41.14 |
Cansino Biologics December 24, 2024 Stock Price Synopsis
Various analyses of Cansino Biologics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Cansino Stock. It can be used to describe the percentage change in the price of Cansino Biologics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Cansino Stock.| Cansino Biologics Price Action Indicator | (0.19) | |
| Cansino Biologics Price Rate Of Daily Change | 1.00 | |
| Cansino Biologics Accumulation Distribution | 23,562 | |
| Cansino Biologics Price Daily Balance Of Power | (0.10) |
Cansino Biologics December 24, 2024 Stock Price Analysis
Cansino Stock Price History Data
The price series of Cansino Biologics for the period between Wed, Sep 25, 2024 and Tue, Dec 24, 2024 has a statistical range of 34.11 with a coefficient of variation of 15.38. The prices are distributed with arithmetic mean of 58.59. The median price for the last 90 days is 61.36. The company issued dividends on 2022-08-23.| Open | High | Low | Close | Volume | ||
| 12/24/2024 | 61.12 | 62.00 | 60.70 | 61.23 | 1,123,750 | |
| 12/23/2024 | 63.69 | 64.03 | 61.20 | 61.36 | 1,380,092 | |
| 12/20/2024 | 63.39 | 64.31 | 63.01 | 63.52 | 1,077,344 | |
| 12/19/2024 | 62.78 | 63.51 | 61.80 | 63.28 | 1,328,300 | |
| 12/18/2024 | 63.98 | 64.29 | 63.00 | 63.29 | 1,140,079 | |
| 12/17/2024 | 64.38 | 65.81 | 63.50 | 63.68 | 1,556,100 | |
| 12/16/2024 | 64.53 | 65.39 | 63.59 | 64.08 | 1,165,152 | |
| 12/13/2024 | 66.43 | 66.43 | 64.35 | 64.39 | 1,719,697 | |
| 12/12/2024 | 67.57 | 67.58 | 65.33 | 66.54 | 2,018,017 | |
| 12/11/2024 | 68.49 | 69.85 | 67.45 | 67.55 | 1,891,883 | |
| 12/10/2024 | 70.50 | 70.55 | 68.29 | 68.49 | 2,406,197 | |
| 12/09/2024 | 70.28 | 70.90 | 67.65 | 68.29 | 2,377,146 | |
| 12/06/2024 | 67.48 | 70.53 | 67.04 | 70.37 | 3,470,228 | |
| 12/05/2024 | 65.94 | 67.37 | 65.49 | 67.04 | 1,632,649 | |
| 12/04/2024 | 67.65 | 67.65 | 65.10 | 65.66 | 2,038,968 | |
| 12/03/2024 | 68.13 | 68.36 | 66.21 | 67.66 | 2,274,642 | |
| 12/02/2024 | 66.50 | 68.45 | 65.81 | 67.99 | 2,548,683 | |
| 11/29/2024 | 64.68 | 66.88 | 63.34 | 66.50 | 2,565,965 | |
| 11/28/2024 | 64.51 | 65.50 | 63.51 | 65.50 | 2,257,211 | |
| 11/27/2024 | 64.88 | 65.22 | 62.25 | 64.50 | 1,910,335 | |
| 11/26/2024 | 63.75 | 66.50 | 63.29 | 63.88 | 2,281,607 | |
| 11/25/2024 | 62.15 | 64.20 | 62.15 | 63.90 | 2,306,955 | |
| 11/22/2024 | 67.70 | 67.88 | 62.08 | 62.11 | 3,030,696 | |
| 11/21/2024 | 67.23 | 69.31 | 66.16 | 67.12 | 2,409,264 | |
| 11/20/2024 | 65.94 | 68.46 | 65.94 | 67.60 | 3,195,963 | |
| 11/19/2024 | 62.79 | 66.70 | 62.12 | 66.06 | 3,918,001 | |
| 11/18/2024 | 63.95 | 64.89 | 61.35 | 61.94 | 2,437,068 | |
| 11/15/2024 | 67.23 | 68.38 | 63.90 | 63.96 | 2,887,276 | |
| 11/14/2024 | 70.63 | 70.63 | 67.52 | 67.52 | 2,599,354 | |
| 11/13/2024 | 68.99 | 71.28 | 67.57 | 70.65 | 5,095,137 | |
| 11/12/2024 | 72.70 | 75.00 | 69.16 | 69.46 | 8,318,288 | |
| 11/11/2024 | 61.35 | 73.75 | 60.90 | 73.75 | 7,250,142 | |
| 11/08/2024 | 61.52 | 62.79 | 60.80 | 61.46 | 3,277,745 | |
| 11/07/2024 | 58.69 | 60.30 | 58.11 | 60.19 | 2,245,231 | |
| 11/06/2024 | 57.60 | 61.75 | 57.10 | 59.13 | 3,746,552 | |
| 11/05/2024 | 56.00 | 57.64 | 55.16 | 57.50 | 2,198,113 | |
| 11/04/2024 | 55.40 | 56.22 | 54.73 | 55.93 | 1,620,433 | |
| 11/01/2024 | 56.67 | 57.22 | 54.66 | 54.66 | 2,631,620 | |
| 10/31/2024 | 57.89 | 58.50 | 56.41 | 56.58 | 2,833,410 | |
| 10/30/2024 | 56.14 | 59.90 | 56.00 | 57.84 | 3,995,829 | |
| 10/29/2024 | 58.14 | 58.46 | 55.66 | 55.81 | 2,692,015 | |
| 10/28/2024 | 57.09 | 57.70 | 56.00 | 57.37 | 1,990,934 | |
| 10/25/2024 | 55.74 | 57.98 | 55.74 | 57.10 | 2,486,325 | |
| 10/24/2024 | 56.17 | 57.53 | 55.73 | 56.00 | 2,590,874 | |
| 10/23/2024 | 56.44 | 57.16 | 55.78 | 56.28 | 2,628,900 | |
| 10/22/2024 | 54.89 | 56.73 | 54.22 | 55.78 | 2,806,781 | |
| 10/21/2024 | 53.72 | 55.91 | 53.44 | 54.76 | 2,969,018 | |
| 10/18/2024 | 50.60 | 55.28 | 50.50 | 53.80 | 3,172,129 | |
| 10/17/2024 | 51.31 | 52.42 | 50.73 | 50.73 | 1,726,858 | |
| 10/16/2024 | 51.07 | 52.25 | 50.62 | 50.99 | 1,739,445 | |
| 10/15/2024 | 53.00 | 54.20 | 51.88 | 51.89 | 2,174,335 | |
| 10/14/2024 | 53.05 | 54.15 | 51.01 | 53.65 | 2,753,221 | |
| 10/11/2024 | 59.19 | 59.19 | 51.73 | 53.00 | 3,432,938 | |
| 10/10/2024 | 59.00 | 60.97 | 57.30 | 57.45 | 4,500,156 | |
| 10/09/2024 | 61.50 | 63.13 | 56.40 | 56.48 | 5,626,043 | |
| 10/08/2024 | 66.00 | 66.16 | 58.03 | 64.10 | 7,416,239 | |
| 09/30/2024 | 48.50 | 55.20 | 48.48 | 55.18 | 5,920,120 | |
| 09/27/2024 | 43.92 | 46.05 | 43.75 | 46.00 | 2,033,847 | |
| 09/26/2024 | 41.25 | 43.18 | 41.20 | 43.06 | 1,840,670 | |
| 09/25/2024 | 41.56 | 42.51 | 41.30 | 41.41 | 2,066,440 | |
| 09/24/2024 | 39.86 | 41.15 | 39.52 | 41.14 | 1,797,000 |
About Cansino Biologics Stock history
Cansino Biologics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cansino is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cansino Biologics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cansino Biologics stock prices may prove useful in developing a viable investing in Cansino Biologics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 284.6 M | 259.1 M | |
| Net Loss | -1 B | -993.6 M |
Cansino Biologics Quarterly Net Working Capital |
|
Cansino Biologics Stock Technical Analysis
Cansino Biologics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Sign In To Macroaxis Now
Sign In To MacroaxisSign in to explore Macroaxis' wealth optimization platform and fintech modules |
| All Next | Launch Module |
Cansino Biologics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cansino Biologics' price direction in advance. Along with the technical and fundamental analysis of Cansino Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cansino to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1237 | |||
| Jensen Alpha | 0.7354 | |||
| Total Risk Alpha | 0.5901 | |||
| Sortino Ratio | 0.1847 | |||
| Treynor Ratio | 3.01 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Cansino Stock analysis
When running Cansino Biologics' price analysis, check to measure Cansino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansino Biologics is operating at the current time. Most of Cansino Biologics' value examination focuses on studying past and present price action to predict the probability of Cansino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cansino Biologics' price. Additionally, you may evaluate how the addition of Cansino Biologics to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Transaction History View history of all your transactions and understand their impact on performance |